The inherent high vulnerability of dopaminergic neurons toward mitochondrial toxins may contribute to the etiology of Parkinson′s disease

The inherent high vulnerability of dopaminergic neurons toward mitochondrial toxins may contribute to the etiology of Parkinson′s disease

Bibliographic Details
Main Author:	Kandatege Wimalasena
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2016-01-01
Series:	Neural Regeneration Research

Similar Items

Metabolic energy decline coupled dysregulation of catecholamine metabolism in physiologically highly active neurons: implications for selective neuronal death in Parkinson’s disease
by: Kandatege Wimalasena, et al.
Published: (2024-02-01)

Vulnerability of mesostriatal dopaminergic neurons in Parkinson’s disease
by: Tomás González-Hernández, et al.
Published: (2010-10-01)

The Convergence of Alpha-Synuclein, Mitochondrial, and Lysosomal Pathways in Vulnerability of Midbrain Dopaminergic Neurons in Parkinson’s Disease
by: Georgia Minakaki, et al.
Published: (2020-12-01)

PARKINSON’S DISEASE: ANIMAL MODELS AND DOPAMINERGIC CELL VULNERABILITY
by: Javier eBlesa, et al.
Published: (2014-12-01)

Mitochondrial Phenotypes in Parkinson’s Diseases—A Focus on Human iPSC-Derived Dopaminergic Neurons
by: Leonie M. Heger, et al.
Published: (2021-12-01)

Molecular determinants of selective dopaminergic vulnerability in Parkinson’s disease: an update
by: Lars eBrichta, et al.
Published: (2014-12-01)

Roles of FGF20 in dopaminergic neurons and Parkinson’s disease
by: Nobuyuki eItoh, et al.
Published: (2013-05-01)

Elevated COUP-TFII expression in dopaminergic neurons accelerates the progression of Parkinson's disease through mitochondrial dysfunction.
by: Chung-Yang Kao, et al.
Published: (2020-06-01)

Selective dopaminergic vulnerability in Parkinson’s disease: new insights into the role of DAT
by: Maged M. Harraz, et al.
Published: (2023-08-01)

Deficiency in endocannabinoid synthase DAGLB contributes to early onset Parkinsonism and murine nigral dopaminergic neuron dysfunction
by: Zhenhua Liu, et al.
Published: (2022-06-01)

Degeneration of dopaminergic neurons due to metabolic alterations and Parkinson’s disease
by: Juhyun eSong, et al.
Published: (2016-03-01)

Induced dopaminergic neurons: A new promise for Parkinson’s disease
by: Zhimin Xu, et al.
Published: (2017-04-01)

Mitochondrial DNA damage: Molecular marker of vulnerable nigral neurons in Parkinson's disease
by: Laurie H. Sanders, et al.
Published: (2014-10-01)

Vulnerable Parkin Loss-of-Function Drosophila Dopaminergic Neurons Have Advanced Mitochondrial Aging, Mitochondrial Network Loss and Transiently Reduced Autophagosome Recruitment
by: Juliana Cackovic, et al.
Published: (2018-02-01)

Roles of neuronal lysosomes in the etiology of Parkinson's disease
by: Mattia Volta
Published: (2024-01-01)

Developmental pathways linked to the vulnerability of adult midbrain dopaminergic neurons to neurodegeneration
by: Nilima Prakash
Published: (2022-12-01)

CALBINDIN CONTENT AND DIFFERENTIAL VULNERABILITY OF MIDBRAIN EFFERENT DOPAMINERGIC NEURONS IN MACAQUES
by: Iria G Dopeso-Reyes, et al.
Published: (2014-12-01)

Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain Iron Accumulation disorders
by: Rachel M. Wise, et al.
Published: (2022-12-01)

Regional vulnerability of mesencephalic dopaminergic neurons prone to degenerate in Parkinson's disease: A post-mortem study in human control subjects
by: Lixia Lu, et al.
Published: (2006-08-01)

Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease
by: Domingo Afonso-Oramas, et al.
Published: (2009-12-01)

Mitochondrial Dysfunction in Dopaminergic Neurons Derived from Patients with LRRK2- and SNCA-Associated Genetic Forms of Parkinson’s Disease
by: Anna S. Vetchinova, et al.
Published: (2023-10-01)

Genetic analysis of transcription factors in dopaminergic neuronal development in Parkinson's disease
by: Yuwen Zhao, et al.
Published: (2024-02-01)

Pathophysiological Features of Nigral Dopaminergic Neurons in Animal Models of Parkinson’s Disease
by: Ezia Guatteo, et al.
Published: (2022-04-01)

AAV.shRNA-mediated downregulation of ROCK2 attenuates degeneration of dopaminergic neurons in toxin-induced models of Parkinson's disease in vitro and in vivo
by: Kim-Ann Saal, et al.
Published: (2015-01-01)

The inherent susceptibility of dorsal motor nucleus cholinergic neurons to the neurodegenerative process in Parkinson's Disease
by: Allan eMcCarthy, et al.
Published: (2013-01-01)

Dietary plant lectins appear to be transported from the gut to gain access to and alter dopaminergic neurons of Caenorhabditis elegans, a potential etiology of Parkinson’s disease
by: Jolene eZheng, et al.
Published: (2016-03-01)

GUCY2C signaling limits dopaminergic neuron vulnerability to toxic insults
by: Lara Cheslow, et al.
Published: (2024-04-01)

Dendritic involvement in inhibition and disinhibition of vulnerable dopaminergic neurons in healthy and pathological conditions
by: R.C. Evans
Published: (2022-10-01)

Representation of spontaneous movement by dopaminergic neurons is cell-type selective and disrupted in parkinsonism
by: Dodson, P, et al.
Published: (2016)

CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson’s disease
by: Bengoa-Vergniory, N, et al.
Published: (2020)

Celastrol Inhibits Dopaminergic Neuronal Death of Parkinson’s Disease through Activating Mitophagy
by: Ming-Wei Lin, et al.
Published: (2019-12-01)

Src Inhibition Attenuates Neuroinflammation and Protects Dopaminergic Neurons in Parkinson’s Disease Models
by: Hanyu Yang, et al.
Published: (2020-02-01)

Molecular Imaging of Striatal Dopaminergic Neuronal Loss and the Neurovascular Unit in Parkinson Disease
by: Jana Ivanidze, et al.
Published: (2020-09-01)

Safranal-promoted differentiation and survival of dopaminergic neurons in an animal model of Parkinson’s disease
by: Yi Zhao, et al.
Published: (2018-01-01)

CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson’s disease
by: Nora Bengoa-Vergniory, et al.
Published: (2020-09-01)

Book Review: Dopaminergic Neuron Transplantation in the Weaver Mouse Model of Parkinson's Disease
by: Rania Shamekh, et al.
Published: (2004-01-01)

Assessment of dopaminergic neuron degeneration in a C. elegans model of Parkinson’s disease
by: Konstantinos Palikaras, et al.
Published: (2022-06-01)

Irisin protect the Dopaminergic neurons of the Substantia nigra in the rat model of Parkinson’s disease
by: Sam Zarbakhsh, et al.
Published: (2019-07-01)

Dl-3-n-Butylphthalide Rescues Dopaminergic Neurons in Parkinson’s Disease Models by Inhibiting the NLRP3 Inflammasome and Ameliorating Mitochondrial Impairment
by: Rongfang Que, et al.
Published: (2021-12-01)

A Focus on Astrocyte Contribution to Parkinson’s Disease Etiology
by: Giselle Prunell, et al.
Published: (2022-11-01)